Study period 1 | Study period 2 | |||
---|---|---|---|---|
TC (mg/dL) | Test (mean ± SEM) | Control (mean ± SEM) | ||
0 week | 12 weeks | 14 weeks | 26 weeks | |
Group 1a | 228 ± 12 | 235 ± 13 | 246 ± 10 | 224 ± 10 |
Control (mean ± SEM) | Test (mean ± SEM) | |||
0 week | 12 weeks | 14 weeks | 26 weeks | |
Group 2b | 211 ± 14 | 233 ± 10 | 224 ± 14 | 232 ± 11 |
TG (mg/dL) | Test (mean ± SEM) | Control (mean ± SEM) | ||
Group 1a | 0 week | 12 weeks | 14 weeks | 26 weeks |
123 ± 9 | 139 ± 15 | 182 ± 20 | 175 ± 23 | |
Control (mean ± SEM) | Test (mean ± SEM) | |||
Group 2b | 0 week | 12 weeks | 14 weeks | 26 weeks |
142 ± 15 | 185 ± 15 | 171 ± 16 | 164 ± 19 | |
LDL (mg/dL) | Test (mean ± SEM) | Control (mean ± SEM) | ||
Group 1a | 0 week | 12 weeks | 14 weeks | 26 weeks |
163 ± 11 | 168 ± 11 | 169 ± 10 | 151 ± 8 | |
Control (mean ± SEM) | Test (mean ± SEM) | |||
Group 2b | 0 week | 12 weeks | 14 weeks | 26 weeks |
137 ± 14 | 152 ± 9 | 147 ± 11 | 153 ± 10 | |
HDL (mg/dL) | Test (mean ± SEM) | Control (mean ± SEM) | ||
Group 1a | 0 week | 12 weeks | 14 weeks | 26 weeks |
39.5 ± 2.1 | 39.0 ± 1.8 | 40.3 ± 1.9 | 37.3 ± 2.0 | |
Control (mean ± SEM) | Test (mean ± SEM) | |||
Group 2b | 0 week | 12 weeks | 14 weeks | 26 weeks |
43.9 ± 2.8 | 42.5 ± 2.1 | 42.8 ± 2.8 | 44.8 ± 2.3 | |
Study Period 1 | Study Period 2 | |||
TC:LDL | Test (mean ± SEM) | Control (mean ± SEM) | ||
0 week | 12 weeks | 14 weeks | 26 weeks | |
Group 1a | 1.43 ± 0.04 | 1.49 ± 0.05 | 1.42 ± 0.03 | 1.47 ± 0.03 |
Control (mean ± SEM) | Test (mean ± SEM) | |||
0 week | 12 weeks | 14 weeks | 26 weeks | |
Group 2b | 1.63 ± 0.06 | 1.56 ± 0.03 | 1.56 ± 0.05 | 1.55 ± 0.04 |
TC:HDL | Test (mean ± SEM) | Control (mean ± SEM) | ||
0 week | 12 weeks | 14 weeks | 26 weeks | |
Group 1a | 6.28 ± 0.40 | 5.69 ± 0.50 | 3.95 ± 0.28 | 4.20 ± 0.32 |
Control (mean ± SEM) | Test (mean ± SEM) | |||
0 week | 12 weeks | 14 weeks | 26 weeks | |
Group 2b | 5.22 ± 0.54 | 5.62 ± 0.34 | 5.50 ± 0.38 | 5.53 ± 0.43 |
LDL:HDL | Test (mean ± SEM) | Control (mean ± SEM) | ||
0 week | 12 weeks | 14 weeks | 26 weeks | |
Group 1a | 4.33 ± 0.35 | 4.28 ± 0.28 | 6.29 ± 0.39 | 5.89 ± 0.37 |
Control (mean ± SEM) | Test (mean ± SEM) | |||
0 week | 12 weeks | 14 weeks | 26 weeks | |
Group 2b | 3.38 ± 0.48 | 3.69 ± 0.28 | 3.62 ± 0.32 | 3.71 ± 0.36 |
AI | Test (mean ± SEM) | Control (mean ± SEM) | ||
0 week | 12 weeks | 14 weeks | 16 weeks | |
Group 1a | 0.49 ± 0.05 | 0.54 ± 0.06 | 0.61 ± 0.06 | 0.64 ± 0.7 |
Control (mean ± SEM) | Test (mean ± SEM) | |||
0 week | 12 weeks | 14 weeks | 16 weeks | |
Group 2b | 0.50 ± 0.06 | 0.62 ± 0.04 | 0.59 ± 0.05 | 0.54 ± 0.06 |